Mengis Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,916
| Closed | -$326K | – | 170 |
|
|
2023
Q2 | $326K | Sell |
3,916
-200
| -5% | -$16.6K | 0.07% | 140 |
|
|
2023
Q1 | $314K | Sell |
4,116
-325
| -7% | -$24.8K | 0.07% | 138 |
|
|
2022
Q4 | $368K | Sell |
4,441
-550
| -11% | -$45.6K | 0.08% | 126 |
|
|
2022
Q3 | $395K | Sell |
4,991
-2,730
| -35% | -$216K | 0.09% | 125 |
|
|
2022
Q2 | $573K | Sell |
7,721
-130
| -2% | -$9.65K | 0.13% | 112 |
|
|
2022
Q1 | $705K | Buy |
7,851
+2,180
| +38% | +$196K | 0.14% | 111 |
|
|
2021
Q4 | $634K | Buy |
5,671
+3,801
| +203% | +$425K | 0.12% | 120 |
|
|
2021
Q3 | $235K | Buy |
1,870
+50
| +3% | +$6.28K | 0.05% | 165 |
|
|
2021
Q2 | $246K | Hold |
1,820
| – | – | 0.05% | 162 |
|
|
2021
Q1 | $246K | Hold |
1,820
| – | – | 0.05% | 160 |
|
|
2020
Q4 | $256K | Hold |
1,820
| – | – | 0.06% | 151 |
|
|
2020
Q3 | $202K | Buy |
+1,820
| New | +$202K | 0.06% | 152 |
|